Gilead Sciences Inc/ US3755581036 /
2024-11-14 9:05:32 AM | Chg. - | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
87.95EUR | - | 50 Turnover: 4,397.50 |
-Bid Size: - | -Ask Size: - | 104.65 bill.EUR | - | - |
Assets
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,674 | 2,276 | 2,865 | 3,295 | 4,006 | ||||||
Intangible Assets | 11,073 | 10,247 | 8,971 | 17,100 | 15,738 | ||||||
Long-Term Investments | 1,598 | 11,601 | 20,485 | 11,184 | 1,423 | ||||||
Fixed Assets | 16,950 | 27,076 | 36,532 | 38,460 | 27,839 | ||||||
Inventories | 1,386 | 1,955 | 1,587 | 801 | 814 | ||||||
Accounts Receivable | 4,635 | 5,854 | 4,514 | 3,851 | 3,327 | ||||||
Cash and Cash Equivalents | 10,027 | 12,851 | 8,229 | 7,588 | 17,940 | ||||||
Current Assets | 17,714 | 24,763 | 20,445 | 31,823 | 35,836 | ||||||
Total Assets | 34,664 | 51,839 | 56,977 | 70,283 | 63,675 |
Liabilities
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 955 | 1,178 | 1,206 | 814 | 790 | ||||||
Long-term debt | 11,921 | 21,195 | 26,346 | 30,795 | 24,574 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 156 | - | - | - | - | ||||||
Liabilities | 18,845 | 32,726 | 37,614 | 49,782 | 42,141 | ||||||
Share Capital | 2 | 1 | 1 | 1 | 1 | ||||||
Total Equity | 15,819 | 19,113 | 19,363 | 20,501 | 21,534 | ||||||
Minority Interests | 393 | 579 | 476 | 59 | 147 | ||||||
Total liabilities equity | 34,664 | 51,839 | 56,977 | 70,283 | 63,675 |
Income Statement
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 24,890 | 32,639 | 30,390 | 26,107 | 22,127 | ||||||
Depreciation (total) | 125 | 161 | - | - | - | ||||||
Operating Result | 15,265 | 22,193 | 17,633 | 14,124 | 8,200 | ||||||
Interest Income | -412 | -688 | -964 | -1,118 | -1,077 | ||||||
Income Before Taxes | 14,856 | 21,659 | 17,097 | 13,529 | 7,799 | ||||||
Income Taxes | 2,797 | 3,553 | 3,609 | 8,885 | 2,339 | ||||||
Minority Interests Profit | 42 | -2 | -13 | 16 | 5 | ||||||
Net Income | 12,101 | 18,108 | 13,501 | 4,628 | 5,455 |
Per Share
Cash Flow
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 12,818 | 20,329 | 16,669 | 11,898 | 8,400 | ||||||
Cash Flow from Investing Activities | -1,823 | -12,475 | -11,985 | -16,069 | 14,355 | ||||||
Cash Flow from Financing | -3,025 | -4,963 | -9,347 | 3,393 | -12,318 | ||||||
Decrease / Increase in Cash | 7,914 | 2,824 | -4,622 | -641 | 10,352 | ||||||
Employees | 7,000 | 8,000 | 9,000 | 10,000 | 11,000 |